Tissue Biomarker Discovery Service
Tissue biomarkers provide valuable insights into the underlying biological processes, disease progression, and treatment response. At Alfa Cytology, a leading preclinical contract research organization (CRO), we specialize in offering comprehensive tissue biomarker discovery services to support cancer research and drug development.
Overview of Tissue Biomarker Discovery in Cancer Research
Cancer is a complex and heterogeneous disease that requires a multifaceted approach for accurate diagnosis and targeted treatment. Tissue biomarkers are quantitative descriptors that reflect functional, morphological, and spatial patterns within tissues.
Fig.1 The Tissue Phenomics workflow. (Harder N, et al., 2018)
- By analyzing tissue samples, researchers can identify specific biomarkers that are associated with distinct cancer subtypes, prognostic outcomes, and potential therapeutic targets.
- Tissue biomarker discovery bridges the gap between genomics, proteomics, and clinical observations, unlocking a wealth of knowledge that can revolutionize cancer diagnostics and therapeutic strategies.
Our Services
At Alfa Cytology, we offer a wide range of comprehensive tissue biomarker discovery services tailored to the specific needs of our clients in the field of cancer research. Our services include, but are not limited to:
Biomarker Identification and Validation
Our team combines advanced molecular profiling techniques, such as next-generation sequencing, gene expression analysis, and immunohistochemistry, to analyze tissue samples and identify biomarkers that are associated with specific cancer types, disease stages, or therapy responses.
Biomarker Profiling and Characterization
Once biomarkers are identified and validated, we perform comprehensive profiling and characterization assays. We utilize high-throughput technologies, integrating genomic, transcriptomic, proteomic, and histopathological data to uncover complex correlations and identify potential therapeutic targets.
Biomarker Assay
Development
Our team designs and optimizes assays tailored to the specific biomarkers of interest, ensuring sensitivity, specificity, and reproducibility. By offering customized biomarker assays, we enable our clients to effectively evaluate biomarker expression in tissue samples, facilitating further investigations.
Our Advantages
Largest Toolbox
Strong Expertise
One-stop Solution
Short Turnaround
At Alfa Cytology, we are committed to providing exceptional tissue biomarker discovery services that empower our clients in their pursuit of groundbreaking discoveries. By analyzing tissue biomarkers, we provide a comprehensive characterization of tumor biology, including molecular subtypes, genetic alterations, and protein expression patterns. If you are interested in our service, please contact us for more details.
Reference
- Harder, N., et al.; (2018). Tissue Phenomics for prognostic biomarker discovery in low-and intermediate-risk prostate cancer. Scientific reports, 8(1), 4470.
For research use only.
Related Services
